ALFA Concalls
Every earnings call, live and summarised
Earnings calls
Every Meghmani Organics earnings call we streamed: the live audio and our summary of what management said.
Consolidated Q2 net profit jumped 193% to ₹33.9 Cr off a weak base, but H1 revenue rose only 2% and standalone EBITDA was flat. Margin recovery depends on input costs normalising, which management hopes for but does…
Consolidated Q2 net profit jumped 193% to ₹33.9 Cr off a weak base, but H1 revenue rose only 2% and standalone EBITDA was flat. Margin recovery depends on input costs normalising, which management hopes for but does not guide.
No quantified FY28 guidance. Pigment top line ₹600-650 Cr, crop protection margin 15-17% long-term, TiO2 restart undecided.
Meghmani Organics Q1 FY27 revenue fell 12% YoY to INR542cr, but consolidated PAT jumped 280% to INR48.2cr on improved margins and operational efficiencies.
Meghmani Organics reported FY26 standalone revenue of ₹2,091cr (up 4% YoY) and EBITDA of ₹228.7cr (up 27% YoY). Strategy focuses on Brazil expansion and Nano-fertilizer growth.
Meghmani Organics reported FY26 consolidated revenue of ₹2,174 Cr, up 5% YoY, with PAT at ₹28.7 Cr. The company is pivoting towards high-margin Crop Nutrition (Nano Urea) and Titanium Dioxide segments.
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.